These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 22326683)

  • 1. The structures and inhibitory effects of Buame [N-(3-hydroxy-1,3,5(10)-estratrien-17β-yl)-butylamine] and Diebud [N,N'-bis-(3-hydroxy-1,3,5(10)-estratrien-17β-yl)-1,4-butanediamine] on platelet aggregation.
    Flores-García M; Fernández-G JM; León-Martínez M; Hernández-Ortega S; Pérez-Méndez O; Correa-Basurto J; Carreón-Torres E; Tolentino-López LE; Ceballos-Reyes GM; de la Peña-Díaz A
    Steroids; 2012 Apr; 77(5):512-20. PubMed ID: 22326683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet aggregation in whole blood, a new approach for understanding the antiplatelet effect of N-(3-hydroxy-1,3,5(10)-estratrien-17b-yl) butylamine (buame).
    de la Peña A; Flores M; Valente-Acosta B; Quintanar-Trejo L; Hernández-Méndez C; Muñoz-Martínez S; Gatica-Lavin F; Pinzón E
    Proc West Pharmacol Soc; 2009; 52():50-3. PubMed ID: 22128422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of N-(3-hydroxy-1,3,5,(10)estratrien-17 beta-yl)-3-hydroxypropyl-amine (prolame) and estradiol-17 beta on platelet aggregation.
    Baños G; De la Peña A; Izaguirre RR; Mandoki JJ; Mendoza-Patiño N; Rubio-Póo C; Fernández JM
    Proc West Pharmacol Soc; 1991; 34():79-83. PubMed ID: 1788347
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative effect of synthetic aminoestrogens with estradiol on platelet aggregation.
    De la Peña A; Baños G; Izaguirre R; Mandoki JJ; Fernández JM
    Steroids; 1993 Sep; 58(9):407-9. PubMed ID: 8236325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of estrone, estradiol and estriol on platelet aggregation induced by adrenaline and adenosine diphosphate.
    Akarasereenont P; Tripatara P; Chotewuttakorn S; Palo T; Thaworn A
    Platelets; 2006 Nov; 17(7):441-7. PubMed ID: 17074719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of platelet aggregation and adenosine triphosphate release in vitro by 17beta-estradiol and medroxyprogesterone acetate in postmenopausal women.
    Bar J; Lahav J; Hod M; Ben-Rafael Z; Weinberger I; Brosens J
    Thromb Haemost; 2000 Oct; 84(4):695-700. PubMed ID: 11057872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro evaluation of the estrogenic properties of the 17β-(butylamino)-1,3,5(10)-estratrien-3-ol (buame) related to 17β-estradiol.
    Lemini C; Medina M; Avila ME; Cruz-Lemini P; Canchola E; Santillan R; Lemus AE
    Pharmacol Rep; 2012; 64(4):940-50. PubMed ID: 23087146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
    Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hemorrhagin catrocollastatin inhibits collagen-induced platelet aggregation by binding to collagen via its disintegrin-like domain.
    Zhou Q; Dangelmaier C; Smith JB
    Biochem Biophys Res Commun; 1996 Feb; 219(3):720-6. PubMed ID: 8645248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-(1H-pyrazol-1-yl)-2-butylamine derivatives as inhibitors of blood platelet aggregation.
    Ferroni R; Milani L; Simoni D; Orlandini P; Guarneri M; Franzé D; Bardi A
    Farmaco; 1989 May; 44(5):495-502. PubMed ID: 2506876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory signaling of 17β-estradiol in platelet activation: the pivotal role of cyclic AMP-mediated nitric oxide synthase activation.
    Wu GJ; Lee JJ; Chou DS; Jayakumar T; Hsiao G; Chen WF; Sheu JR
    Eur J Pharmacol; 2010 Dec; 649(1-3):140-9. PubMed ID: 20883689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of some cephalosporins and teicoplanin on platelet aggregation.
    Cazzola M; Matera MG; Santangelo G; Lampa E; Angrisani M; Loffreda A; Rossi F
    Int J Clin Pharmacol Res; 1993; 13(2):69-73. PubMed ID: 8354591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of platelet antagonists on the ex vivo inhibitory effects of platelet aggregation].
    Sakata T; Kobayashi K; Katayama Y; Takada T; Matsuyama T
    Rinsho Byori; 1991 Mar; 39(3):315-20. PubMed ID: 2051607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of U46619 induced human platelet aggregation by aspirin.
    Kim JM; Koo YK; Jin J; Lee YY; Park S; Yun-Choi HS
    Platelets; 2009 Mar; 20(2):111-9. PubMed ID: 19235053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gallopamil and changes of adenosine diphosphate- and collagen-induced thrombocyte aggregation].
    Költringer P; Langsteger W; Lind P; Pierer G; Reisecker F; Eber O
    Arzneimittelforschung; 1991 Aug; 41(8):786-8. PubMed ID: 1781797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet activity of inositol hexaphosphate (IP6).
    Vucenik I; Podczasy JJ; Shamsuddin AM
    Anticancer Res; 1999; 19(5A):3689-93. PubMed ID: 10625941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagen-induced platelet aggregation: the role of adenine nucleotides and the release reaction.
    Kattlove H; Gomez MH
    Thromb Diath Haemorrh; 1975 Dec; 34(3):795-805. PubMed ID: 813326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of a new platelet aggregation inhibitor with dissociative effect on ADP-induced platelet aggregation, from the venom of Protobothrops elegans (Sakishima-habu).
    Oyama E; Furudate N; Senuki K; Takahashi H
    Toxicon; 2009 Jun; 53(7-8):706-12. PubMed ID: 19254737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New orally active non-peptide fibrinogen receptor (GpIIb-IIIa) antagonists: identification of ethyl 3-[N-[4-[4-[amino[(ethoxycarbonyl) imino]methyl]phenyl]-1,3-thiazol-2-yl]-N-[1-[(ethoxycarbonyl)methyl]pip erid -4-yl]amino]propionate (SR 121787) as a potent and long-acting antithrombotic agent.
    Badorc A; Bordes MF; de Cointet P; Savi P; Bernat A; Lalé A; Petitou M; Maffrand JP; Herbert JM
    J Med Chem; 1997 Oct; 40(21):3393-401. PubMed ID: 9341914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole blood platelet aggregation in humans and animals: a comparative study.
    Soloviev MV; Okazaki Y; Harasaki H
    J Surg Res; 1999 Apr; 82(2):180-7. PubMed ID: 10090827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.